The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Calithera Biosciences, Inc. | COM | 13089P101 | 12,280 | 2,161,915 | SH | SOLE | 2,161,915 | 0 | 0 | ||
LendingClub Corporation | COM | 52603A109 | 41,233 | 4,967,784 | SH | SOLE | 4,967,784 | 0 | 0 | ||
Amicus Therapeutics, Inc. | COM | 03152W109 | 15,074 | 1,783,948 | SH | SOLE | 1,783,948 | 0 | 0 |